🇨🇭·5h agoIndustry
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Publisher
R
Roche Newsroom
Switzerland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Roche Newsroom
- Region
- Switzerland
- Scope
- Industry
- Published
- July 23, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on roche.com
Leave the platform to read the original full article on the publisher site.
Source: Roche Newsroom
Scope: Industry
Related coverage
More related coverage
Chugai Pharmaceutical News/5h ago
エフ・ホフマン・ラ・ロシュの2026年中間決算発表について
Chugai Pharmaceutical/5h ago
F. Hoffmann-La Roche Announces Half Year Results 2026
Otsuka Pharmaceutical/6h ago
Announcement of Price Revisions for Specified Products
Natco Pharma/10h ago